ECMO support for viral induced cardiogenic shock: a bridge too far?

The global coronavirus disease 2019 (COVID-19) pandemic has captured the world's conscious thought in a way not experienced in most of our lifetimes. In a world where Presidents conduct foreign policy by Twitter, we are not lacking information volume. In medicine, our version of the gold standard for truth is two well-conducted randomised controlled trials with concordant results. With the pandemic impacting health services so rapidly, decisions about treatment options may be required well ahead of this level of certainty.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Editorials Source Type: research